Fingolimod

Related products

• 

  Multiple sclerosis

  Glatiramer acetate

  【Product name】COPAXONE

  [English common name]Glatirameracetate

  [Chinese common name]Glatiramer acetate

  [English name]L-GLUTAMICACIDPOLYMERWITHL

  [Chinese other name]L-alanine-L-glutamic acid

  [indications] preventionMultiple sclerosisThe recurrence.

  [Usage and Dosage] The usual adult dose for subcutaneous injection of glatiramer acetate is 20 mg once daily.

  [Storage] Refrigerate COPAXONE from 2 ° C to 8 ° C (36 ° F to 46 ° F). If necessary, patients can store COPAXONE at room temperature, 15 ° C to 30 ° C (59 ° F to 86 ° F) for up to a month, but preferably refrigerated. Avoid exposure to higher temperatures or strong light. Do not freeze COPAXONE. If the COPAXONE syringe is frozen, it should be discarded.

  [Tips] Some of the information on this site comes from the Internet and is only used internally by pharmacists or medical staff. It is not a substitute for doctors to diagnose face to face. Please consult a professional pharmacist for specific medications. Please refer to the actual product manual or the actual product for the product content.
• 

  Multiple sclerosis , Multiple sclerosis

  Triflurane

  【Product name】Aubagio

  [English common name]Teriflunomide

  [Chinese common name]Triflurane

  [English name]Teriflunomide [INN], Active metabolite of leflunomide

  [Chinese other name]

  [Indications] AUBAGIO is a pyrimidine synthesis inhibitor suitable for use inMultiple sclerosisTreatment of relapsing patients.

  [Usage and Dosage] 7mg or 14mg orally once a day, with or without food.

  [Storage] The drug does not require any special storage conditions.

  [Tips] Some of the information on this site comes from the Internet and is only used internally by pharmacists or medical staff. It is not a substitute for doctors to diagnose face to face. Please consult a professional pharmacist for specific medications. Please refer to the actual product manual or the actual product for the product content.
• 

  Multiple sclerosis

  Ocrelizumab

  [product name] ocreves

  [English common name] ocrelizumab

  [Chinese common name]

  [English name]

  [Chinese other name]

  [Indications] Ocrevus is a treatmentMultiple sclerosisThe drug – Multiple Sclerosis is a neurological inflammatory disease that can cause symptoms such as weakness, difficulty walking and vision problems.
  Ocrevus is used in two groups of patients: adults with relapsing multiple sclerosis (RMS) who have a sudden onset (relapse) and then have a mild or asymptomatic period; with primary progressive multiple sclerosis (PPMS) Adults, as time goes on, the symptoms will gradually deteriorate.
  Ocrevus contains the active substance ocrelizumab.

  [Usage and Dosage] Ofcrevus enters the vein as an infusion (drop). The first two infusions were separated for two weeks and then infused every six months. Other medications (corticosteroids and antihistamines) are given to patients prior to each infusion to help prevent potentially dangerous reactions. If a reaction occurs during the infusion, a slower response can be stopped or given. Patients should be monitored during the infusion process and monitored at least one hour thereafter, and facilities that manage severe reactions should be readily available.

  [Storage]

  [Tips] Some of the information on this site comes from the Internet and is only used internally by pharmacists or medical staff. It is not a substitute for doctors to diagnose face to face. Please consult a professional pharmacist for specific medications. Please refer to the actual product manual or the actual product for the product content.
• 

  Multiple sclerosis

  Interferon beta-1

  [product name] Avonex, Plegridy, Betaferon, PEGASYS, PEGINTRON, IMMUNOMAX, INTRON, REBIF, Extavia

  [English common name]Interferon beta-1b

  [Chinese common name]Interferon beta-1

  [English name]Betaferon

  [Chinese other name]

  [Indications] PLEGRIDY is an interferon beta forMultiple sclerosisTreatment of recurrent patients.

  【Dosage】
  (1) Only for subcutaneous injection.
  (2) Recommended dose: 125μg every 14 days.
  (3) The PLEGRIDY dose should be adjusted by spotting, starting with 63 μg on day 1, 94 μg on day 15, and 125 μg (complete dose) on day 29
  (4) A health care professional hard-training patient with appropriate techniques for subcutaneous injection of a prefilled pen or syringe.
  (5) Analgesics and/or antipyretics may be helpful in reducing flu-like symptoms during treatment.

  [Storage] Do not store above 25 °C. Do not freeze.

  [Tips] Some of the information on this site comes from the Internet and is only used internally by pharmacists or medical staff. It is not a substitute for doctors to diagnose face to face. Please consult a professional pharmacist for specific medications. Please refer to the actual product manual or the actual product for the product content.